Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Research & Development (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Research & Development for 3 consecutive years, with $8.4 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 16.4% to $8.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.2 million through Dec 2025, down 1.61% year-over-year, with the annual reading at $38.2 million for FY2025, 1.58% down from the prior year.
  • Research & Development hit $8.4 million in Q4 2025 for Camp4 Therapeutics, down from $9.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $10.7 million in Q4 2023 to a low of $8.4 million in Q4 2025.
  • Historically, Research & Development has averaged $9.8 million across 3 years, with a median of $9.8 million in 2023.
  • Biggest YoY gain for Research & Development was 10.16% in 2025; the steepest drop was 16.4% in 2025.
  • Year by year, Research & Development stood at $10.7 million in 2023, then fell by 6.24% to $10.0 million in 2024, then dropped by 16.4% to $8.4 million in 2025.
  • Business Quant data shows Research & Development for CAMP at $8.4 million in Q4 2025, $9.4 million in Q3 2025, and $10.3 million in Q2 2025.